Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Life, illuminated.

Advancing fluorescent technology to help improve patient care.

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function. More >>
To contact us for more information
about the TGFR click here.
For approved transdermal kidney function products see ifu.medibeacon.com for Indication for Use and Important Safety Information about the TGFR including Lumitrace® injection.
Now Approved
Transdermal Kidney Function Technology
Via PMA No. P2300019 for human use
PRECLINICAL
MediBeacon technology is available for preclinical use.
CLINICAL
MediBeacon technologies are progressing through clinical trials.*
MediBeacon is a medical technology company specializing in the advances of fluorescent tracer agents and transdermal measurement. The science is complex, but the outcomes are simple to understand. How it works >>
Focused on Providing Kidney Insights to Clinicians

The MediBeacon Transdermal GFR System (TGFR) is engineered to allow detection of the change in levels of a fluorescent GFR tracer agent over time via a sensor placed on the patient’s skin. The TGFR Monitor displays this information in the form of a transdermal GFR (tGFR) which may be useful in the understanding of kidney function.

Transdermal GFR Across Skin Tones

The Transdermal GFR System (TGFR) has been designed to report a tGFR across the full range of human skin colors as quantified by the Fitzpatrick Skin Phototype (FSP).

Understanding Renal Function is a Significant Clinical Challenge

According to the CDC 2023 Chronic Kidney Disease (CKD) Factsheet, more than 1 in 7 adults in the US are estimated to have CKD, and approximately 1 in 5 adults with high blood pressure and 1 in 3 adults with diabetes have CKD. The MediBeacon Transdermal GFR System (TGFR) received FDA approval to assess kidney function.

There are no limits to our thinking or what that thinking can accomplish.
Focus areas for
fluorescent agent-
based systems include:
Nephrology

Point of care assessment of renal function
-Learn More

Gastroenterology

Point of care gastrointestinal
permeability measurement
-Learn More

Ophthalmology

Fluorescent agent angiography
-Learn More

Surgery

Fluorescent tracer agent
use in surgery
-Learn More